RCEL - AVITA Medical, Inc.
NEXT EARNINGS:
May 14, 2026
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$3.50
DETAILS
HIGH:
$3.50
LOW:
$3.50
MEDIAN:
$3.50
CONSENSUS:
$3.50
DOWNSIDE:
35.06%
Market Cap:
133.90M
Volume:
722,992
Avg Volume:
213,833
52 Week Range:
3.22-10.29
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
1.80
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
260
IPO Date:
2012-05-14
EPS (TTM):
-1.74
P/E Ratio:
-1.98
Revenue (TTM):
71.61M
Total Assets:
56.39M
Total Debt:
2.13M
Cash & Equiv:
10.24M
Rev Growth (5Y):
34.1%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
N/A
Debt/Equity:
10.22
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-12 | $-0.04 | $-0.48 | +91.4% | $17.6M | $25.7M | -31.4% |
| 2025-11-06 | $-0.46 | $-0.43 | -7.0% | $17.1M | $26.9M | -36.5% |
| 2025-08-07 | $-0.38 | $-0.26 | -46.2% | $12.0M | $40.2M | -70.1% |
| 2025-05-08 | $-0.53 | $-0.39 | -35.9% | $11.6M | $37.4M | -68.9% |
| 2025-02-13 | $-0.44 | $-0.30 | -46.7% | $11.4M | $31.6M | -63.9% |
| 2024-11-07 | $-0.62 | $-0.42 | -47.6% | $13.5M | $35.4M | -61.8% |
| 2024-08-08 | $-0.60 | $-0.59 | -1.7% | $10.1M | $14.7M | -31.2% |
| 2024-05-13 | $-0.73 | $-0.26 | -180.8% | $7.2M | $11.1M | -34.8% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 71.61M | 64.25M | 50.14M | 34.42M | 33.02M | 29.23M | 14.26M | 5.47M | 1.26M | 1.18M | 1.00M | 985,647 |
| Net Income | (48.59M) | (61.84M) | (35.38M) | (26.66M) | (25.14M) | (26.58M) | (42.03M) | (25.10M) | (17.21M) | (11.51M) | (10.27M) | (7.87M) |
| EPS | -1.74 | -2.39 | -1.40 | -1.57 | -1.03 | -2.07 | -3.00 | -1.12 | -1.84 | -1.72 | -2.06 | -2.23 |
| Total Assets | 56.39M | 79.71M | 111.64M | 98.26M | 116.02M | 125.50M | 82.46M | 25.78M | 23.00M | 7.67M | 8.60M | 5.44M |
| Total Debt | 2.13M | 45.98M | 42.41M | 918,000 | 1.64M | 878,000 | 1.92M | 0 | 134,247 | 0 | 0 | 0 |
| Cash & Equivalents | 10.24M | 14.05M | 22.12M | 18.16M | 55.51M | 110.75M | 73.64M | 20.17M | 14.82M | 3.79M | 4.17M | 2.97M |
| Operating Cash Flow | (31.20M) | (48.94M) | (38.01M) | (19.09M) | (18.04M) | (25.90M) | (22.75M) | (19.25M) | (9.54M) | (6.58M) | (5.93M) | (4.87M) |
| Free Cash Flow | (31.20M) | (58.27M) | (39.46M) | (19.61M) | (18.52M) | (27.07M) | (23.59M) | 0 | (9.81M) | 0 | 0 | (3.76M) |
| FCF per Share | -1.12 | -2.25 | -1.56 | -0.78 | -0.76 | -1.33 | -1.16 | N/A | -1.06 | N/A | N/A | -1.06 |
| Book Value | (16.65M) | 4.50M | 49.06M | 84.74M | 104.62M | 115.66M | 72.40M | 20.83M | 18.99M | 5.12M | 6.85M | 4.22M |
| Cash & ST Investments | 18.18M | 35.88M | 89.06M | 79.34M | 85.16M | 110.75M | 73.64M | 20.17M | 14.82M | 3.79M | 4.17M | 2.97M |
| ROC Equity | N/A | -13.75 | -0.72 | -0.31 | -0.24 | -0.23 | -0.58 | -1.20 | -0.91 | -2.25 | -1.50 | -1.87 |